Your browser doesn't support javascript.
loading
N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators.
Zhao, Lei; Tao, Jun-Yan; Zhang, Shu-Ling; Jin, Feng; Pang, Ran; Dong, Ji-Hua.
Afiliación
  • Zhao L; Department of Hepatology & Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430072, Department of Neurosurgery and Central Lab, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P.R. China.
Evid Based Complement Alternat Med ; 7(1): 97-106, 2010 Mar.
Article en En | MEDLINE | ID: mdl-18955281
ABSTRACT
Melilotus suaveolens Ledeb is a traditional medicinal plant for treating inflammation-related disease. This explores the inner anti-inflammatory mechanism of n-butanol extract from M. suaveolens Ledeb. Inflammatory cellular model was established by lipopolysaccharide intervention on RAW264.7 cell line. Levels of secreted cytokines TNF-α, IL-1ß, IL-6, NO and IL-10 in supernatant, mRNA expression of TNF-α, COX-2, iNOS and HO-1, protein expression of COX-2 and HO-1, activation of NF-κB and ingredients in the extract were assayed by ELISA, real time quantitative PCR, western blot, immunocytochemical test and HPLC fingerprint test, respectively. As a result, the extract could not only markedly reduce the production of pro-inflammatory mediators to different extents by blocking NF-κB activation but also promote the release of anti-inflammatory mediator HO-1 significantly. Each 1 g extract contained 0.023531 mg coumarin and another two high polar ingredients, probably saponins. It can be concluded that the extract has similar effects on antagonizing pro-inflammatory mediators and cytokines like Dexamethasone, and has effects on promoting the production of anti-inflammatory mediators.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Evid Based Complement Alternat Med Año: 2010 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Evid Based Complement Alternat Med Año: 2010 Tipo del documento: Article